Inventiva S.A. American Depository Shares (IVA) vs Lexicon Pharmaceuticals (LXRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Lexicon Pharmaceuticals (LXRX) has outperformed Inventiva S.A. American Depository Shares (IVA) over the past year, gaining 15.8% versus a loss of 39.0%. Over five years, LXRX leads with a -71.4% price change compared with -74.9% for IVA. Inventiva S.A. American Depository Shares is the larger company by market cap ($794.9 million vs $783.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IVA | LXRX |
|---|---|---|
| Share price | $3.37 | $1.76 |
| Market cap | $794.88M | $783.12M |
| 1-day change | -2.75% | +0.57% |
| YTD return | -27.63% | +53.04% |
| 1-year return | -39.04% | +15.79% |
| 5-year return | -74.89% | -71.43% |
| EPS (TTM) | $-0.62 | $-0.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.98 | $2.68 |
| 52-week low | $3.11 | $1.10 |
| Distance from 52-week high | -57.85% | -34.33% |
| Average volume | 1.40M | 2.91M |
| Shares outstanding | 236.22M | 444.96M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LXRX has outperformed IVA by 54.8 percentage points over the past year.
IVA vs LXRX FAQ
Which is bigger, Inventiva S.A. American Depository Shares or Lexicon Pharmaceuticals?
Inventiva S.A. American Depository Shares (IVA) is larger, with a market capitalization of $794.88M compared with $783.12M for Lexicon Pharmaceuticals (LXRX).
Which stock has performed better over the past year, IVA or LXRX?
LXRX returned +15.79% over the past 12 months, compared with -39.04% for IVA (price return, excluding dividends). Past performance does not predict future results.
Are Inventiva S.A. American Depository Shares and Lexicon Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.